Literature DB >> 34406470

External validation of different difficulty scoring systems of laparoscopic liver resection for hepatocellular carcinoma.

Haiping Lin1,2, Yang Bai1, Mengqiu Yin1,2, Zewei Chen1,2, Shian Yu3.   

Abstract

BACKGROUND: Several difficulty scoring systems (DSSs) have been proposed for evaluating difficulty of laparoscopic liver resection (LLR) and no study has validated their performance in a hepatocellular carcinoma (HCC)-only cohort at the same time.
METHODS: All cases with HCC that underwent LLR from January 2015 to December 2020 in our center were retrospectively collected. Performance of the IWATE-DSS, Halls-DSS, Hasegawa-DSS, and Kawaguchi-DSS in predicting perioperative outcomes was evaluated. Subgroup analyses were conducted to compare perioperative outcomes between surgeons on the learning curve and surgeons that have gone through the learning curve.
RESULTS: For all four DSSs, there were significant distributions of applying bleeding control, surgical time, estimated blood loss, postoperative major complications, and postoperative hospital stay among different groups of each DSS (P all < 0.05). Conversion to laparotomy or not was significantly distributed in different groups of the IWATE-DSS (P = 0.006) and Halls-DSS (P = 0.022), while it was not in the Hasegawa-DSS (P = 0.056) and Kawaguchi-DSS (P = 0.183). Trend tests showed that the conversion rates increased with higher DSS points in the IWATE-DSS (P < 0.001) and the Kawaguchi-DSS (P = 0.021), while not in the Halls-DSS (P = 0.064) and the Hasegawa-DSS (P = 0.068). In the medium and advanced/expert difficulty-level subgroups defined by the IWATE-DSS, there were larger estimated blood loss (P in medium-difficulty group = 0.009; P in the advanced/expert difficulty group = 0.004) and longer postoperative hospital stay (P in the medium-difficulty group = 0.012; P in the advanced/expert group = 0.035) in the learner-performed cases.
CONCLUSIONS: All DSSs performed well in predicting applying bleeding control, surgical time, estimated blood loss, postoperative major complications, and postoperative hospital stay, while only the IWATE-DSS was able to predict whether conversion to laparotomy or not for HCC patients underwent LLR. The IWATE-DSS was also able to help surgeons on the LLR learning curve choose cases and guide clinical practices.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Difficulty scoring system; External validation; Laparoscopic liver resection

Mesh:

Year:  2021        PMID: 34406470     DOI: 10.1007/s00464-021-08687-5

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   3.453


  4 in total

Review 1.  Analysis of economic impact of laparoscopic liver resection according to surgical difficulty.

Authors:  Quentin Dubray; Sophie Laroche; Ecoline Tribillon; Brice Gayet; Marc Beaussier; Alexandra Nassar; Isabelle Aminot; Sandra Camps; David Fuks
Journal:  Surg Endosc       Date:  2020-10-13       Impact factor: 4.584

2.  Long-term abdominal wall benefits of the laparoscopic approach in liver left lateral sectionectomy: a multicenter comparative study.

Authors:  Benjamin Darnis; Kayvan Mohkam; Nicolas Golse; Eric Vibert; Daniel Cherqui; François Cauchy; Olivier Soubrane; Jean-Marc Regimbeau; Jeanne Dembinski; Jean Hardwigsen; Philippe Bachelier; Christophe Laurent; Stéphanie Truant; Guillaume Millet; Mickaël Lesurtel; Emmanuel Boleslawksi; Jean-Yves Mabrut
Journal:  Surg Endosc       Date:  2020-09-28       Impact factor: 4.584

3.  Validation and comparison of the Iwate, IMM, Southampton and Hasegawa difficulty scoring systems for primary laparoscopic hepatectomies.

Authors:  Brian K P Goh; Mikel Prieto; Nicholas Syn; Ye-Xin Koh; Jin-Yao Teo; Ser-Yee Lee; Alexander Y Chung; Chung-Yip Chan
Journal:  HPB (Oxford)       Date:  2020-10-03       Impact factor: 3.647

4.  Laparoscopic resection reduces superficial surgical site infection in liver surgery.

Authors:  Satoshi Matsukuma; Yukio Tokumitsu; Yuki Nakagami; Yoshitaro Shindo; Hiroto Matsui; Masao Nakajima; Michihisa Iida; Nobuaki Suzuki; Shigeru Takeda; Hiroaki Nagano
Journal:  Surg Endosc       Date:  2021-01-04       Impact factor: 4.584

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.